Genetikos ir molekulinės medicinos draugija - company info and details

Company age: 2 y. 7 mo.

Update

Company overview

Company name Genetikos ir molekulinės medicinos draugija
Company code 306702789
Registered address Kauno r. sav., Samylų sen., Laumėnų k., Beržų g. 16, LT-53135
Registration date 2024-03-26 Company age: 2 y. 7 mo.
Phone Phone
Email Not disclosed (personal)
Website None
Company manager For registered members only Log in
Revenue (2025) 10,935 € History
Profit (2025) 200 € History
Number of employees 0
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Association
NACE activity Activities of other membership organisations n.e.c.
Sector Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form Private without foreign capital
Beneficiary of support Yes, since 2025-03-12
NVO Non-governmental organization since 2025-03-24

Description

This description was generated by artificial intelligence.
Genetikos ir molekulines medicinos draugija (company code 306702789) is an operational public association registered on 26 March 2024. It operates as a non-profit institution providing services to households, with private ownership, and is governed by a CEO with a board/council. The entity is classified as micro-sized. Its registered address is Beržu g. 16, Laumenu k., Samylai eldership, Kaunas District Municipality, Kaunas County. The company’s EVRK activity code is T.94.99.00, covering Activities of other membership organisations n.e.c. Financially, the association reported revenue of €200 in 2024 for a 280-day period and ended that year with €200 in net profit, equity and total assets. In 2025, for a full 364-day financial year, revenue increased to €10.9K and total assets reached €8.0K. The latest figures show a strong increase in turnover from the initial year of operations.

Download a detailed company report

Make confident decisions with all the information about Genetikos ir molekulinės medicinos draugija. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report